The use of a natural medicine, S-adenolsylmethionine (SAM-e) in the treatment of Fibromyalgia

Completed

• Conditions: Fibromyalgia Chronic Fatigue Syndrome; Fibromyalgia; Chronic Fatigue Syndrome; Musculoskeletal - Other muscular and skeletal disorders

• Registration Number: ACTRN12607000485437
• Lead Sponsor: Deakin University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2007-09-21
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 70

Inclusion Criteria

Diagnosis of Fibromyalgia by a medical practitioner.

Exclusion Criteria

Pregnancy, Concurrent manic illness.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Symptom reduction in Fibromyalgia. Specifically we expect a reduction in depressive symptoms, sleep disturbances and gastric disturbances.[Measured at three points in time: pre-trial and at 4 and 8 weeks]

Secondary Outcome Measures

Name	Time	Method
Examination of dose-response data and the nature of the placebo effect in these conditions.[Measured at three points in time: pre-trial and at 4 and 8 weeks]